Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi Centre, Single Arm, Observational Study on Safety and Efficacy of MabThera Plus Chemotherapy as 1st Line Treatment in Patients With DLBCL or FL

NCT01340443 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT01340443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01340443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi Centre, Single Arm, Observational Study on Safety and Efficacy of MabThera Plus Chemotherapy as 1st Line Treatment in Patients With DLBCL or FL
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
January 19, 2011
Completion date
July 15, 2016
Enrollment
314 (actual)
Sites
24

Conditions

As the registry lists them; a condition with its own page is linked.

diffuse large b-cell lymphoma